Table 4.
Univariate and multivariate hazard ratio for composite outcome of time to all-cause death or heart failure hospitalization
| Parameters | Univariate analysis |
Multivariate analysis I |
Multivariate analysis II |
||||||
|---|---|---|---|---|---|---|---|---|---|
| HR | 95% CI | P value | HR | 95% CI | P value | HR | 95% CI | P value | |
| CSP vs CP | 0.68 | 0.48–0.98 | .04 | 0.53 | 0.31–0.91 | .02 | 0.61 | 0.42–0.89 | <.01 |
| Age | 1.01 | 0.99–1.0.3 | .155 | ||||||
| Female | 0.82 | 0.58–1.2 | .27 | ||||||
| Hypertension | 1.7 | 1.1–2.5 | .03 | 1.56 | 0.94–2.5 | .07 | |||
| Diabetes | 1.64 | 1.12–2.4 | .01 | 1.5 | 0.98–2.30 | .06 | |||
| CAD | 1.47 | 1.0–2.1 | .03 | 1.3 | 0.89–1.9 | .17 | |||
| History of CHF | 1.8 | 1.3–2.7 | <.01 | 1.9 | 1.1–3.2 | <.01 | 1.85 | 1.3–2.7 | <.01 |
| Type of AF | 0.48 | 0.29–0.78 | <.01 | 0.62 | 0.34–1.1 | .06 | |||
| Beta blockers | 0.36 | 0.24–0.95 | .02 | 0.42 | 0.19–0.98 | .05 | 0.39 | 0.18–0.86 | .02 |
| ACE/ARB/ARNI | 1.27 | 0.88–1.8 | .2 | ||||||
| Baseline QRS | 1 | 1–1.1 | .02 | 1.0 | 0.99–1.1 | .99 | |||
| Paced QRS | 1.1 | 0.99–1.0 | .08 | 1.0 | 0.99–1.1 | .82 | |||
| Baseline LVEF | 0.99 | 0.98–1.01 | .07 | 1.0 | 0.98–1.03 | .57 | |||
| EF <50% | 1.4 | 0.95–1.95 | .08 | 0.99 | 0.46–2.1 | .98 | |||
| CSP vs BVP | 0.59 | 0.39–0.89 | .01 | 0.6 | 0.32–1.3 | .21 | |||
| HBP vs LBBAP | 0.80 | 0.41–1.58 | .53 | ||||||
| CSP vs RVP | 0.85 | 0.56–1.33 | .47 | ||||||
| BVP vs RVP | 0.72 | 0.45–1.1 | .19 | ||||||